Evidence map›Paper›PMID 31938314›Full record

ArticleInternational journal of clinical and experimental pathology2018

Dysregulation of CD44v6 may lead to recurrent spontaneous abortion by inhibiting the proliferation and migration of trophoblast cells.

Min Hu, Yan-Xiang Cheng, Xiao Yang, Jia Yu, Jinling Huang, Li Hong

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Min HuDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Yan-Xiang ChengDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Xiao YangDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Jia YuDepartment of Hepatobiliary Surgery, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Jinling HuangDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Li HongDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan University Wuhan, Hubei, PR China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the establishment and continuation of a successful pregnancy, the proliferation, migration, and invasion of trophoblast cells play essential roles. Impaired trophoblast function has been reported to be involved in recurrent spontaneous abortion (RSA) but the potential mechanisms are still unknown. CD44 variant domain 6 (CD44v6) is a transmembrane glycoprotein that has been known for decades to be expressed in the placenta. In this study, we investigated the effect of CD44v6 on proliferation and migration of trophoblast cells. Our results show that CD44v6 expression in the villi is lower in RSA patients than in women with normal pregnancies. Furthermore, downregulation of CD44v6 leads to a reduction in proliferation and migration in the human trophoblast cell line HTR-8/SVneo, along with decreased expression and nuclear translocation of NF-κB. These results suggest that decreased expression of CD44v6 may cause miscarriage by downregulating trophoblast cell proliferation via the NF-κB pathway.

Indexed as

CD44v6HTR-8/SVneo cellinvasionNF-κBproliferationrecurrent spontaneous abortiontrophoblast cell

Identifiers

PMID31938314
PMCPMC6958214
OpenAlexW3004436814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.